Senate antitrust subcommittee health care agenda
Executive Summary
Rx industry competition issues will be examined by Senate Judiciary/Antitrust, Competition Policy & Consumer Rights Subcommittee in 2003, subcommittee Chairman Mike DeWine (R-Ohio) announces. Committee will focus on "the state of competition in the prescription drug industry to ensure that consumers benefit from vigorous competition in the prescription drug market," agenda says. Subcommittee also plans continued inquiry into group purchasing organizations' "reforms to their business practices" (1"The Pink Sheet" May 13, 2002, p. 18)...